Clinical Trial Update: Pilot Study for Patients With Poor Response to Deferasirox [Phase 4]

View source ↗

Summary

Phase 4 pilot trial update on patients with poor response to Deferasirox.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia Major
• Transfusion-dependent Hemachromatosis

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Transfusion-dependent Hemachromatosis, Thalassemia Major | Phase 4 | Status: COMPLETED | Results posted: 2019-02-06